The persistent rise in the
incidence of different types of cancer is the primary factor driving the global
novel drug delivery system (NDDS) in cancer therapy market, says Transparency
Market Research in its latest report. The report, titled “Novel Drug
Delivery Systems (NDDS) in Cancer Therapy Market -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 -
2020”, states that expanding at a remarkable 23.70% CAGR from 2014 to 2020, the
global market is anticipated to rise from a value of US$3.6 bn in 2013 to
US$15.9 bn in 2020.
The NDDS in cancer therapy market
is categorized on the basis of technology into liquid embolics, nanoparticles,
and embolization particles. Valued at US$3.3 bn in 2013, nanoparticles emerged
as the leading technology segment in terms of revenue. This segment is
projected to expand at an astounding 24.70% CAGR from 2014 to 2020, presenting
the most promising opportunities for players within the NDDS in cancer therapy
market. The segment of liquid embolics is forecast to expand at a 4.90% CAGR by
2020.
On the basis of geography, the
global NDDS in cancer therapy market is segmented into North America, Asia
Pacific, Europe, and Rest of the World. Accounting for a share of 46.60% in the
overall market in 2013, North America has emerged as the leading regional segment.
Expanding at an impressive 24.90% CAGR from 2014 to 2020, North America is
anticipated to hold 49.70% of the global NDDS in cancer therapy market by the
end of the forecast period. The NDDS in cancer therapy market in this region is
fueled by favorable reimbursement scenario, rising number of people suffering
from various types of cancer, and technologically advanced healthcare
infrastructure.
Accounting for 29.20% of the
global NDDS in cancer therapy market, Europe became the second largest regional
segment in 2013, propelled by technological advances, strong pipeline, and
development of innovative products. The Asia Pacific market for NDDS is
anticipated to exhibit a 22.60% CAGR
during the forecast period owing to rapid growth in emerging economies such as
Japan, New Zealand, China, India, and Australia. The NDDS in cancer therapy
market in this region is also fueled by increasing market penetration by major
players and improvement in reimbursement scenario.
Request A Sample
Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3590
The
key participants in the global NDDS in cancer therapy market include Mo-Sci
Corporation, Cook Medical, Inc., Sirtex Medical, Inc., Bind Therapeutics,
EmboMedics, Inc., BTG plc, Kobo Products, Inc., Advanced Medical Isotope
Corporation, Nanobiotix, CeloNova BioSciences, Inc., Eckert & Ziegler
BEBIG, Boston Scientific Corporation, Polysciences, Inc., Covidien, plc,
Cospheric LLC, Terumo Medical Corporation, and Merit Medical Systems, Inc.
These players are profiled in the research report based on attributes such as
company and financial overview, business strategies, and recent developments.
NDDS
in Cancer Therapy Market, by Technology
·
Embolization
Particles
o Current Technologies
§ Drug Eluting Beads
§ Others (PVA particles,
microspheres, gelatin-based)
o Emerging Technologies
§ Selective Internal
Radiation Therapy (SIRT)
§ TheraSphere
§ SIR-Spheres
§ Holmium-based Microspheres
o Liquid Embolics
§ Onyx (LES and HD-500)
§ TRUFILL nBCA LES
o Nanoparticles
NDDS
in Cancer Therapy Market, by Geography
·
North
America
·
Europe
·
Asia
Pacific
·
Rest
of the World (RoW)
About Us
Transparency
Market Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive blend of
quantitative forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources and various tools and
techniques to gather and analyze information.
TMR’s data
repository is continuously updated and revised by a team of research experts so
that it always reflects the latest trends and information. With extensive
research and analysis capabilities, Transparency Market Research employs
rigorous primary and secondary research techniques to develop distinctive data
sets and research material for business reports.
Contact
us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/